Selected article for: "cell transplant and hematologic malignancy"

Author: Ogimi, Chikara; Waghmare, Alpana; Kuypers, Jane; Xie, Hu; Leisenring, Wendy; Yeung, Cecilia; Seo, Sachiko; Choi, Su-Mi; Jerome, Keith; Englund, Janet; Boeckh, Michael
Title: Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplantation Recipients and Hematologic Malignancy Patients
  • Document date: 2016_10_25
  • ID: swbw5q7b_1
    Snippet: Background. Fatal pneumonia attributed to human coronaviruses (HCoVs) in hematopoietic cell transplant (HCT) recipients has been reported but systematic studies on the possible role of HCoV in lower respiratory tract disease (LRTD) in HCT and hematologic malignancy (HM) patients are limited......
    Document: Background. Fatal pneumonia attributed to human coronaviruses (HCoVs) in hematopoietic cell transplant (HCT) recipients has been reported but systematic studies on the possible role of HCoV in lower respiratory tract disease (LRTD) in HCT and hematologic malignancy (HM) patients are limited.

    Search related documents:
    Co phrase search for related documents
    • cell transplant and HCoV possible role: 1
    • cell transplant and HCT recipient: 1, 2, 3
    • cell transplant and hematologic HCT malignancy: 1, 2, 3
    • cell transplant and hematopoietic cell transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell transplant and hematopoietic cell transplant HCT recipient: 1
    • cell transplant and HM patient: 1
    • cell transplant and LRTD tract disease: 1
    • cell transplant and possible role: 1, 2
    • cell transplant and respiratory LRTD tract disease: 1
    • cell transplant and tract disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • fatal pneumonia and hematopoietic cell transplant: 1, 2
    • fatal pneumonia and possible role: 1
    • fatal pneumonia and tract disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • HCoV possible role and hematopoietic cell transplant: 1
    • HCoV possible role and LRTD tract disease: 1
    • HCoV possible role and possible role: 1
    • HCoV possible role and respiratory LRTD tract disease: 1
    • HCoV possible role and tract disease: 1
    • HCT recipient and hematologic HCT malignancy: 1